Lymphoma

 

Relapsed or Refractory Lymphoid Malignancies

 

  • MAGNIFY:  Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.

 

For more information, contact Cheryl Patz, RN, OCN, CCRC, at 360-788-8238.